HTAs

Summary of CADTH Drug Portfolio Information Session   Date: Thursday, November 1, 2018 Time: 1:30 pm to 4:00 pm Presenters: Brian O’Rourke, Brent Fraser, Alex Chambers, Trevor Richter, Heather Logan, Tarry Ahuja, Michelle Mujoomdar, Harindra Wijeysundera Purpose: An opportunity for all interested stakeholders to get the latest information about priority initiatives and process changes from CADTH’s pharmaceutical reviews portfolio, including the CADTH Common Drug Review (CDR), the CADTH pan-Canadian Oncology…

Aligned Reviews Between Health Canada (HC) and Health Technology Assessment Organizations (HTAs)   Date: September 26th, 2018 Time: 10:00 AM - 11:30 AM Presenters: Alex Chambers (CADTH), Virginie Landreville (INESSS), M Coyer (HC), and T Richter (CADTH) Purpose: To describe the HC-HTA (CADTH and INESSS) aligned review process in more detail, and discuss any questions regarding this initiative. This initiative aims to improve regulatory review in order to obtain more…